OPTIMI IN THE NEWS: Companies sense opportunity in psychedelic legalisation
Click on the link for full story. Companies sense opportunity in psychedelic legalisation | The Canberra Times | Canberra, ACT
July 4, 2023
Regulator Filings
Consultants
Legal Counsel: Norton Rose Fulbright
Auditor: Smythe CPA
Transfer Agent: Endeavor Trust
Corporate Visibility & Investor Relations: Kydder Group
Stock Information
Trading Symbol: CSE: OPTI | OTC:OPTHF |
FRA: 8BN
CUSIP Number: 68405H100
ISIN Number: CA68405H1001
WKN: A2QQEL
Issued & Outstanding: (30/06/2022) 80,451,883
Incorporated: BC / May 27, 2020
Year End: September 30th
Product Disclaimer: Optimi Health products are still being investigated through a clinically validated development program for the purpose of applying for market authorization.
The safety and efficacy of our products has not been formally established.
© Copyright 2024 Optimi Health All rights reserved.
